Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",48290,289,1.09 [0.89-1.35],0.4056410317401423
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",50025,382,1.15 [0.96-1.38],0.1204742452707015
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",49497,2686,1.14 [1.06-1.22],0.0001661435343676
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Candidiasis,50062,830,1.10 [0.97-1.24],0.1349288785078967
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,48538,6825,1.13 [1.09-1.18],1.1199182557846348e-08
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),48743,6260,1.10 [1.05-1.15],2.5854457441922656e-05
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,49577,2382,1.16 [1.08-1.25],5.208513387230352e-05
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,49887,169,1.03 [0.78-1.36],0.8293056536422264
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,46045,1887,1.16 [1.07-1.26],0.0003602323280837
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,44512,2155,1.20 [1.11-1.29],2.606056832814246e-06
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,44238,496,1.17 [1.00-1.37],0.0552933973250615
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,35195,3875,1.13 [1.07-1.20],3.384972131482285e-05
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,43953,759,1.34 [1.18-1.51],4.715217255376209e-06
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,49990,2795,1.17 [1.09-1.25],6.259962285388631e-06
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Mycoses,50209,977,1.10 [0.98-1.23],0.1139975505509424
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,48616,1805,1.15 [1.06-1.25],0.0008738596133191
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,50081,2080,1.14 [1.05-1.23],0.0011878428605732
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,47578,383,1.16 [0.97-1.39],0.1141024781151911
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,50308,99,1.61 [1.18-2.20],0.0025833056349236
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other septicaemia,49823,1822,1.15 [1.06-1.25],0.0011655898770881
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,49864,146,1.32 [0.99-1.74],0.054591299925374
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Other viral diseases,50151,304,1.49 [1.24-1.80],2.5129868867546392e-05
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",50115,268,1.49 [1.22-1.82],7.748879990313284e-05
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,47629,818,1.25 [1.11-1.41],0.0002581439591392
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,47344,533,1.07 [0.91-1.25],0.4284883642005355
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,47405,210,1.58 [1.27-1.96],4.941793621636815e-05
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,50264,100,0.89 [0.61-1.29],0.5236619430777167
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,50181,292,1.09 [0.88-1.34],0.4416296149729071
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Viral warts,49987,98,1.07 [0.75-1.53],0.711176413394509
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],50010,121,1.11 [0.80-1.53],0.5398775217334104
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign lipomatous neoplasm,49733,574,0.91 [0.78-1.07],0.2512468726622501
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,50134,114,1.00 [0.71-1.40],0.9944455282639412
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,50100,122,1.18 [0.86-1.62],0.305563973894896
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,23124,127,0.87 [0.63-1.21],0.4175547048744334
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",49658,2802,1.00 [0.94-1.07],0.9472166354058028
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm of meninges,50281,111,1.38 [1.01-1.89],0.0440995176791491
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,50182,126,1.15 [0.84-1.57],0.3760676067075473
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,50258,202,1.08 [0.84-1.38],0.5730484697354508
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm of ovary,27056,171,0.94 [0.71-1.24],0.6628555365260089
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm: Ascending colon,50261,698,0.92 [0.80-1.06],0.2553531807599036
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm: Caecum,50263,587,0.98 [0.84-1.14],0.77810287585557
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",50093,139,0.92 [0.67-1.26],0.5967492295984139
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm: Descending colon,50258,421,0.90 [0.75-1.07],0.2375592905388623
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm: Rectum,50183,682,1.01 [0.88-1.16],0.8581641615128496
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,50083,1197,0.99 [0.89-1.10],0.8510438689646407
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Benign neoplasm: Transverse colon,50245,837,0.95 [0.83-1.08],0.4036576638970348
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Carcinoma in situ of breast,22008,134,0.58 [0.41-0.81],0.0017696883721028
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",22099,164,0.78 [0.58-1.05],0.0973622699458159
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",40089,100,3.11 [2.53-3.83],3.811535056893583e-27
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",40123,134,1.34 [1.00-1.81],0.0497063996249461
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",50211,230,0.86 [0.67-1.10],0.2321951826789283
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Haemangioma, any site",50212,226,0.87 [0.68-1.12],0.2738039236325708
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Leiomyoma of uterus,26159,574,0.91 [0.78-1.07],0.2580101880707454
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Lung cancer and mesothelioma,34911,647,1.10 [0.95-1.27],0.2018974706636395
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Lymphoid leukaemia,40089,100,3.14 [2.58-3.83],7.281260177773457e-30
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",40357,368,1.10 [0.91-1.32],0.3376897049816923
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",40382,393,0.95 [0.79-1.15],0.6317132678941122
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",22228,185,0.99 [0.76-1.29],0.9416906113024004
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",40144,155,1.15 [0.86-1.53],0.3573171490403323
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",40195,206,1.14 [0.89-1.47],0.3072218776346075
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",40177,188,1.13 [0.87-1.48],0.3602722551249462
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",22182,139,0.95 [0.70-1.30],0.7685545976932225
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",40169,180,0.97 [0.73-1.27],0.805986262482336
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",19303,1357,1.08 [0.98-1.19],0.1416818107363493
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",40207,218,0.81 [0.63-1.05],0.1169562286100339
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",40131,142,1.42 [1.07-1.89],0.0155354626463176
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,40196,207,1.07 [0.83-1.38],0.5917676221690236
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Melanocytic naevi,49928,393,1.12 [0.94-1.33],0.2190400632730079
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Melanocytic naevi of trunk,50232,169,1.23 [0.95-1.60],0.1169111894857272
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Melanoma in situ,40055,159,1.03 [0.77-1.37],0.8450025769457699
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",40165,176,1.27 [0.98-1.65],0.070403588222665
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",40301,312,1.52 [1.27-1.83],8.242532255845037e-06
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",40432,443,0.94 [0.79-1.13],0.515672400657095
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",40180,191,1.50 [1.18-1.90],0.0008738414101082
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,Other benign neoplasms of skin,49951,293,1.08 [0.88-1.33],0.4573614311084674
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",42080,2091,1.03 [0.95-1.11],0.4942382701338665
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",42193,2204,1.04 [0.96-1.12],0.3294004349972019
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,49747,661,1.23 [1.08-1.41],0.0023369144737443
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,46623,218,1.37 [1.09-1.73],0.0070038710636942
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,49221,135,1.63 [1.24-2.14],0.0003863142913701
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,48763,5639,1.13 [1.07-1.18],9.766393245409218e-07
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,47437,96,1.22 [0.86-1.74],0.264523878611079
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,49492,100,1.34 [0.96-1.88],0.0850289723863904
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,49357,2952,1.13 [1.05-1.20],0.0004020457023473
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,49356,2951,1.12 [1.05-1.20],0.0004357714791123
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,46573,168,1.17 [0.89-1.54],0.2508048821189021
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,49670,2329,1.19 [1.11-1.28],1.4083781332941651e-06
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,49616,224,1.05 [0.82-1.33],0.6996354558709583
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,49209,123,1.13 [0.82-1.55],0.4621327797352268
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,49202,116,1.45 [1.07-1.96],0.0174106003994263
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,49933,541,1.02 [0.88-1.20],0.7718352746234387
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,50102,107,1.20 [0.86-1.68],0.2839223603600231
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",49838,446,0.89 [0.74-1.06],0.1866822801208541
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,47546,205,1.08 [0.84-1.39],0.5515550885504101
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,38900,616,1.21 [1.05-1.39],0.0091457806910355
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,46907,225,1.10 [0.87-1.40],0.4103242611009963
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,46926,244,1.29 [1.03-1.60],0.0237111588317069
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,38392,108,1.45 [1.05-1.98],0.0227494039243076
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,46722,133,1.11 [0.81-1.51],0.5104480796920579
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,45623,463,0.99 [0.83-1.17],0.864944746204005
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",49375,1115,1.01 [0.91-1.13],0.8004213300664987
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,48783,523,1.00 [0.85-1.17],0.9570086383141878
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,48514,254,1.11 [0.89-1.39],0.3635581156465357
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,49617,3028,1.11 [1.04-1.18],0.0017600091820449
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,43804,2934,1.11 [1.04-1.19],0.0017143687440591
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",38415,131,0.93 [0.67-1.29],0.6669529047220092
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",46377,155,0.97 [0.72-1.30],0.8306540270435068
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,38831,547,1.24 [1.07-1.44],0.0045564514622974
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,38401,117,1.41 [1.03-1.91],0.0293882300136674
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,45181,6897,1.13 [1.08-1.18],1.6147206189285227e-08
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,38658,374,1.09 [0.91-1.32],0.3417355250167958
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,39366,1082,1.17 [1.05-1.31],0.0036777224899722
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,50146,628,1.19 [1.04-1.37],0.0139802120650983
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,49779,261,1.29 [1.04-1.59],0.0189341157616268
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,38534,250,1.12 [0.90-1.41],0.3158799279369036
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",38401,117,1.31 [0.95-1.79],0.0955653622721053
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,49251,3029,1.09 [1.02-1.16],0.0123027632473433
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,38789,505,1.18 [1.01-1.39],0.0402354030749787
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,38863,579,1.24 [1.07-1.43],0.0045759016800173
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",39520,1236,1.18 [1.07-1.31],0.0010889986173117
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,38518,234,1.08 [0.85-1.36],0.5500570231054738
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,49763,245,1.26 [1.01-1.57],0.0363978227970409
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,39468,1184,1.09 [0.99-1.22],0.0886368518692254
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,39229,945,1.09 [0.97-1.23],0.1497350530820171
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,45298,138,1.13 [0.83-1.52],0.4398274762242659
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,47998,9714,1.12 [1.08-1.16],1.1740019546375154e-09
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,46319,97,0.93 [0.64-1.36],0.7183691040646945
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,46332,110,1.00 [0.71-1.41],0.9916580560541312
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,49944,3789,0.96 [0.91-1.02],0.1994478196754895
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",49945,3783,0.96 [0.91-1.02],0.1965081924397833
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,46324,102,1.23 [0.88-1.73],0.2317055927861241
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,49639,2348,1.06 [0.99-1.15],0.0990526512916436
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",41378,3094,1.13 [1.06-1.20],0.0002725383819532
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,50282,442,1.14 [0.96-1.35],0.1228695517441359
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,48422,162,1.30 [0.99-1.70],0.059798341392741
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,47491,200,1.00 [0.77-1.30],0.9857758047342104
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,47566,275,1.28 [1.04-1.58],0.0179944489703945
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",38611,327,1.32 [1.09-1.59],0.0040755000470275
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,45793,298,1.16 [0.95-1.43],0.1427173550670668
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,4103,164,1.15 [0.87-1.52],0.3324568394223136
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,4377,493,1.02 [0.87-1.20],0.8210178380967712
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,45615,120,1.35 [1.01-1.81],0.0423041512491351
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,4047,111,1.38 [1.00-1.91],0.0518325711080583
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,49060,3565,1.18 [1.11-1.25],4.0374164112075946e-08
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,48956,696,0.90 [0.78-1.04],0.1561128121562319
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,45871,711,1.14 [1.00-1.30],0.0551681346889911
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,39787,1503,1.13 [1.03-1.24],0.0078620111148892
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",50084,478,1.04 [0.89-1.23],0.6021763560993659
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),48130,321,0.84 [0.68-1.04],0.1069592427076582
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Angina pectoris,45927,2326,1.09 [1.01-1.17],0.0245639536306811
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Aortic aneurysm,48279,470,0.91 [0.77-1.08],0.2765067410217288
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,47925,116,1.51 [1.12-2.03],0.0066972241490023
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",48199,390,1.37 [1.16-1.62],0.0002780098176973
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,31198,3703,0.99 [0.94-1.06],0.8444076132263661
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,AV-block,42394,833,1.08 [0.96-1.23],0.2109699658432051
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",50193,826,0.92 [0.81-1.04],0.1872946590190442
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Cardiac arrest,27874,379,1.30 [1.09-1.55],0.003914994191318
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Cardiomyopathy,41892,331,0.93 [0.75-1.13],0.4570386632047638
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",41748,187,0.88 [0.67-1.16],0.3529746966042814
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,50305,100,1.22 [0.86-1.74],0.2638371923401629
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Conduction disorders,43594,2033,1.04 [0.96-1.13],0.3220377660147964
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,47630,4062,1.13 [1.07-1.20],9.468280990952862e-06
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,43878,14700,1.07 [1.04-1.10],5.371596498519535e-06
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,DVT of lower extremities,47615,517,1.06 [0.90-1.24],0.5011181250064252
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Endocarditis,41704,143,1.13 [0.84-1.52],0.4154406026279394
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Heart failure, strict",49905,2138,1.08 [1.00-1.17],0.047712277204485
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Hypertension,45663,12639,1.08 [1.05-1.12],9.86376703632034e-07
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Hypertension, essential",45697,12673,1.08 [1.05-1.12],7.783302443272943e-07
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Hypertension, portal",49977,145,0.85 [0.62-1.17],0.320226755248101
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",33365,341,1.15 [0.95-1.40],0.1479646460118429
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,33291,267,1.43 [1.17-1.75],0.0004564128567096
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Hypotension,50022,2296,1.10 [1.02-1.18],0.0127387236880228
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,48511,213,1.01 [0.79-1.30],0.9127305494206828
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",47954,4353,1.12 [1.06-1.18],4.11582568995289e-05
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",49573,1085,1.11 [1.00-1.24],0.0607366431360255
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Left bundle-branch block,42262,701,1.14 [0.99-1.30],0.0616406863331564
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,49375,1637,1.12 [1.03-1.23],0.0087596495836385
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",44986,1385,1.16 [1.06-1.28],0.0018092783267175
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",50128,297,1.33 [1.09-1.62],0.0043152992196414
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",50251,609,1.06 [0.92-1.23],0.401759829224841
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Oesophageal varices,47200,102,1.01 [0.71-1.45],0.9490645264807004
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other aneurysm,47959,150,0.99 [0.74-1.33],0.9559603819947948
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other arrhythmias,42385,824,1.15 [1.01-1.30],0.0285783309521102
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,48006,197,1.47 [1.17-1.85],0.0010402267051611
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,48267,458,1.01 [0.85-1.19],0.9514108445004038
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,41910,349,0.99 [0.81-1.20],0.8947733303296367
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other disorders of veins,47290,192,1.07 [0.83-1.39],0.6016482211887122
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,47190,92,1.15 [0.80-1.67],0.4440405201937469
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,47508,122,0.94 [0.67-1.32],0.7318590207981351
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,47360,262,0.97 [0.78-1.22],0.8172515611928095
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,43570,2009,1.04 [0.96-1.13],0.3433007374009318
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,47832,106,1.04 [0.73-1.48],0.8352299164661146
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,48860,1051,1.08 [0.97-1.21],0.1685198535746317
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,49108,673,1.20 [1.05-1.38],0.0070905878272947
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",48577,1191,1.01 [0.91-1.12],0.831054381753231
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,28155,660,0.95 [0.83-1.10],0.5061144052271448
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Peripheral artery disease,48533,782,1.16 [1.02-1.32],0.0193857860578949
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),47772,674,1.04 [0.90-1.19],0.5993082317199119
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Pulmonary embolism,49358,923,1.10 [0.98-1.24],0.1027887631647774
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,50170,1281,1.07 [0.97-1.18],0.1793191169409372
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Right bundle-branch block,42239,678,0.97 [0.84-1.12],0.7024658029075059
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Secondary right heart disease,49099,664,1.21 [1.05-1.38],0.0069516263113893
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,47765,379,1.10 [0.91-1.32],0.3332952220794788
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",49550,1252,1.10 [0.99-1.21],0.0754158166529443
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",49509,1326,1.08 [0.98-1.19],0.1189125468052157
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,48459,116,0.92 [0.65-1.30],0.6297222196354975
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,47965,157,0.90 [0.67-1.20],0.4693534849570012
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Transient ischemic attack,48948,460,1.08 [0.92-1.28],0.3493446639752039
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,48240,502,1.19 [1.02-1.39],0.0264701661283084
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Varicose veins,47923,825,0.98 [0.86-1.11],0.7286436206553075
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,47838,170,0.83 [0.62-1.11],0.2083333315275937
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter IX Diseases of the circulatory system,Venous thromboembolism,49860,1458,1.04 [0.95-1.14],0.4127553950943815
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",50071,697,1.09 [0.95-1.24],0.2296983992159156
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",43994,2774,1.11 [1.04-1.19],0.0028109743685832
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,Any mental disorder,49031,7811,1.08 [1.04-1.12],0.0002349211213794
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",49979,823,1.07 [0.94-1.21],0.3221200573259979
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",44304,3084,1.12 [1.05-1.20],0.0003792824284102
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",41398,178,1.22 [0.94-1.58],0.1325005656216542
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,Smoking dependency,49269,2678,1.13 [1.05-1.21],0.000598954463182
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",44402,3182,1.11 [1.04-1.18],0.0010139233877163
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter V Mental and behavioural disorders,Vascular dementia,49302,250,0.84 [0.66-1.07],0.1568197607238597
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Alzheimer disease,50307,647,1.02 [0.88-1.17],0.830756128601911
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",33904,115,1.22 [0.88-1.69],0.2304824439231725
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Bell's palsy,46846,156,0.95 [0.70-1.27],0.707191021875542
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,47634,944,1.09 [0.97-1.22],0.1675618395830494
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Cerebral cysts,49521,451,1.07 [0.90-1.27],0.4262191945686228
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,50151,628,0.99 [0.85-1.14],0.8723586899818792
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,49326,96,0.92 [0.63-1.35],0.6811617295534345
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,50276,119,1.00 [0.72-1.39],0.9921056400004982
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",49212,142,1.05 [0.78-1.42],0.7451326189827732
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Epilepsy,47263,555,1.01 [0.87-1.18],0.902671367212219
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,49365,2657,1.06 [0.99-1.14],0.1037010982378946
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,50223,1183,1.00 [0.90-1.11],0.9492252696616263
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Falls/tendency to fall,49148,5046,0.99 [0.94-1.04],0.5969045300982712
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Generalized epilepsy,49567,104,1.51 [1.11-2.07],0.0095944699112347
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Hemiplegia,50012,489,0.99 [0.84-1.17],0.9480197831782984
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Hydrocephalus,49192,122,1.31 [0.96-1.78],0.0859140769850384
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,50270,129,1.52 [1.15-2.01],0.0034935073320321
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,46833,143,0.72 [0.52-1.00],0.0471812482082038
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,46842,152,1.50 [1.15-1.95],0.0025233951158359
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Memory loss,49020,214,1.00 [0.78-1.28],0.9809992447690508
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Migraine,47407,699,1.18 [1.03-1.34],0.0149113528190375
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",50168,629,1.16 [1.01-1.34],0.0321072027145381
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Motor neuron disease,34090,264,0.99 [0.79-1.24],0.9097280952284512
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,49985,202,1.07 [0.84-1.38],0.5731004639796575
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",48999,2309,1.09 [1.02-1.18],0.0171772573180702
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Neurological diseases,47424,7330,1.05 [1.00-1.09],0.0356996167344015
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,49626,396,0.94 [0.78-1.13],0.5112548855619282
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",47494,804,1.14 [1.00-1.29],0.0452222217555042
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",50159,572,1.12 [0.97-1.30],0.1346524056201003
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,40019,1266,1.02 [0.92-1.13],0.7149692978510958
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,49214,144,0.99 [0.73-1.34],0.9285710986802038
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Other disorders of nervous system,49343,273,0.90 [0.72-1.13],0.3811940254173404
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,49363,323,1.04 [0.86-1.28],0.6689559680765409
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Other facial nerve disorders,46873,183,0.94 [0.71-1.23],0.6465525086503159
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Other headache syndromes,46816,108,1.03 [0.73-1.47],0.8491629609076627
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Other neurological diseases,50079,1009,1.08 [0.97-1.21],0.1589019191154049
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Other sleep disorders,47790,1082,1.03 [0.92-1.14],0.6585859660847944
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Parkinson's disease,50261,834,0.98 [0.86-1.11],0.7448356867446116
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,49179,109,1.20 [0.86-1.67],0.2771935951390819
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Restless leg syndrome,50306,154,1.06 [0.79-1.42],0.6923270418956888
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Sleep apnoea,49831,931,1.02 [0.90-1.15],0.7719819663529557
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Small fibre neuropathy,49680,93,1.19 [0.83-1.71],0.3317423670135147
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,50282,316,0.96 [0.79-1.19],0.7327788801998687
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,46787,97,1.08 [0.75-1.55],0.6911750414951539
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,50307,654,1.01 [0.88-1.17],0.8746234387572371
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),49231,243,0.83 [0.65-1.06],0.1400568949578046
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,49195,194,1.05 [0.81-1.35],0.7300899655965793
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,49517,773,0.94 [0.83-1.08],0.3798192759568664
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,49965,457,1.02 [0.86-1.21],0.8482257695904303
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,48355,103,1.11 [0.78-1.57],0.5592495417923122
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,48366,114,1.24 [0.90-1.71],0.1863618358615375
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",50099,95,0.97 [0.66-1.41],0.8634427124520804
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,49794,287,1.01 [0.82-1.26],0.907322983666556
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",4058,119,1.40 [1.03-1.91],0.0343355446649687
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,4926,195,1.10 [0.85-1.42],0.4678842763094409
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,49180,179,1.19 [0.92-1.54],0.1944503776553736
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,49887,2026,1.04 [0.96-1.13],0.2843164405553101
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",49591,1339,1.01 [0.92-1.12],0.8050945190579566
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,48689,437,1.02 [0.85-1.21],0.8486705311877573
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",50142,1398,1.02 [0.92-1.12],0.7524949933991333
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,50287,132,1.38 [1.04-1.84],0.027917662838921
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,49999,1255,1.00 [0.90-1.10],0.92799965649879
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",50223,716,1.08 [0.94-1.23],0.2861869214282111
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,50126,348,1.06 [0.88-1.29],0.5218138100028755
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,48366,114,1.05 [0.75-1.48],0.7651692126235409
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,48380,128,1.05 [0.76-1.44],0.7821454511185658
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,48361,109,1.00 [0.70-1.42],0.994909961910488
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,50129,1373,1.06 [0.96-1.17],0.2523199562956051
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,49114,358,0.92 [0.75-1.12],0.3907223899422403
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,48838,94,0.93 [0.64-1.37],0.7208275451674381
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,49701,194,1.10 [0.85-1.42],0.4752292972770041
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,50041,534,1.07 [0.91-1.24],0.4236025152436475
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,49117,373,1.10 [0.91-1.32],0.3305548989565415
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,49993,215,0.94 [0.73-1.21],0.6218226638243443
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,49671,915,1.12 [1.00-1.26],0.0515248111516306
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,49276,275,1.13 [0.91-1.40],0.2694596006401332
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,47171,4199,1.06 [1.01-1.12],0.0286844752043261
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,49970,463,1.04 [0.88-1.24],0.6066185674894027
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,50267,297,1.10 [0.90-1.36],0.3518427764862616
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,49036,784,1.03 [0.90-1.17],0.7032184371856508
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,49632,125,1.09 [0.79-1.50],0.5858827624053388
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,50263,108,1.51 [1.12-2.05],0.0075112112963756
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,48415,163,0.89 [0.67-1.20],0.449685237739694
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,48537,285,1.01 [0.81-1.25],0.928201191910706
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,48093,232,1.21 [0.97-1.52],0.0946679049989176
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,48864,120,1.10 [0.80-1.52],0.5472646656553097
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",47980,119,0.80 [0.56-1.13],0.2048355967230072
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,48924,168,0.90 [0.68-1.20],0.4914064657695257
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",49135,379,1.14 [0.95-1.36],0.1599724190330331
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,48495,243,1.10 [0.87-1.38],0.4148379867106935
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,48075,214,1.30 [1.03-1.64],0.024773796009322
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,48024,163,1.25 [0.95-1.63],0.1084822489229059
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,46489,3517,1.03 [0.96-1.09],0.419544092634637
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,48392,140,1.02 [0.75-1.38],0.9214324427292072
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,49803,802,1.15 [1.02-1.30],0.0276942686249889
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,49115,114,1.36 [0.99-1.85],0.0557036392418103
NFKBIE,NF-kappa-B inhibitor epsilon,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),49332,331,1.19 [0.98-1.44],0.0790461364370784
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,49895,170,0.88 [0.66-1.18],0.3937326024732782
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,50216,234,1.08 [0.85-1.36],0.5309919480912674
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,50051,244,1.11 [0.89-1.40],0.3560400821166121
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,49838,113,1.03 [0.73-1.44],0.8817189919825048
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,49842,117,1.15 [0.84-1.59],0.3815171691420889
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,50108,1742,1.06 [0.97-1.15],0.2108490386641627
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,49615,1249,1.11 [1.00-1.22],0.0505938036764839
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,48610,244,0.81 [0.64-1.03],0.0921590334017034
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,48534,168,1.12 [0.85-1.48],0.407890076046456
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Acute pharyngitis,49832,143,0.95 [0.70-1.30],0.7650192295421299
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,50101,412,0.90 [0.75-1.08],0.2631807826077646
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,49813,124,0.97 [0.70-1.35],0.8521232692414369
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,All influenza,46386,229,1.17 [0.93-1.48],0.1791440970147464
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),46381,224,1.21 [0.96-1.53],0.1069435300980523
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Allergic asthma (mode),34489,225,1.12 [0.89-1.42],0.3313110192986986
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Allergic rhinitis,50051,540,1.02 [0.88-1.19],0.7704808419295316
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",37151,3409,1.05 [0.99-1.12],0.0939486327654635
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",37622,3358,1.06 [1.00-1.13],0.0670768064971397
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),49524,267,1.25 [1.02-1.55],0.0354482821645431
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",46316,159,1.41 [1.09-1.83],0.0097712501009031
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Bronchiectasis,43654,691,1.17 [1.02-1.34],0.0210865781420407
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",43075,112,1.43 [1.05-1.95],0.0217912295428997
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,48353,5390,1.07 [1.02-1.12],0.0057318365849903
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",47628,137,0.92 [0.67-1.26],0.6044879993629108
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Chronic sinusitis,47790,299,1.32 [1.09-1.60],0.0048314626593907
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",49920,2313,1.08 [1.01-1.17],0.0354954627986405
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Deviated nasal septum,47703,212,1.19 [0.94-1.51],0.146357725368327
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,46300,10224,1.07 [1.04-1.11],7.72070829978059e-05
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",48207,716,1.05 [0.92-1.20],0.5012826920740399
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Early onset COPD,48215,608,1.08 [0.94-1.25],0.2810101156327436
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Emphysema,43571,608,1.21 [1.06-1.40],0.0066218718833714
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,47805,550,1.23 [1.06-1.43],0.0054993766142399
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Influenza and pneumonia,49872,3715,1.11 [1.04-1.17],0.0007316826084062
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Interstitial lung disease,47869,614,1.29 [1.12-1.48],0.0003093119286046
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Later onset COPD,48382,1705,1.09 [1.00-1.19],0.0558690725276246
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,50283,637,1.03 [0.90-1.19],0.6434357085258482
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Nasal polyp,47693,202,1.22 [0.96-1.55],0.1108185765836979
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,49820,1867,1.14 [1.05-1.24],0.0013092383655007
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Other diseases of pleura,49848,3852,1.11 [1.05-1.17],0.0005224349868124
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,49115,1624,1.09 [1.00-1.19],0.0630698847070567
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Other pleural conditions,46098,102,1.21 [0.87-1.70],0.2593249780648749
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,50136,768,1.24 [1.10-1.41],0.0006649232743222
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,50101,2520,1.16 [1.09-1.25],1.879493126196361e-05
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Pleural effusion,47912,1916,1.08 [0.99-1.17],0.0685552257397568
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Pleural plaque,46295,299,1.15 [0.94-1.40],0.1877328078687712
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",49387,3230,1.10 [1.03-1.17],0.0032608996926977
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,50159,513,1.01 [0.85-1.18],0.9512459554492452
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Pneumothorax,46223,227,0.97 [0.76-1.23],0.7974877441854037
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Pollen allergy,50261,462,1.08 [0.91-1.27],0.3869809058343317
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Pulmonary oedema,49496,128,0.96 [0.69-1.33],0.8022441146938974
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Respiratory insufficiency,34371,107,1.37 [0.98-1.89],0.0617582661929743
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,49781,1828,1.14 [1.05-1.24],0.0023189149155669
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,48033,542,1.02 [0.88-1.19],0.780010058205002
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Viral pneumonia,46635,478,1.06 [0.90-1.25],0.4658858813513706
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",49552,395,0.98 [0.81-1.18],0.8248817503195682
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,23203,216,0.89 [0.69-1.15],0.3895942053301838
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,35525,126,1.16 [0.85-1.59],0.357229559335917
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Acute appendicitis,49995,286,0.93 [0.74-1.15],0.482620737540869
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Acute gastritis,37874,180,0.99 [0.75-1.30],0.937540242106072
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Acute pancreatitis,46727,346,1.05 [0.87-1.28],0.5949260346465932
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Acute peritonitis,49395,181,1.03 [0.79-1.35],0.8386349048928801
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Alcoholic liver disease,48578,144,0.91 [0.67-1.24],0.55737136330012
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Barrett oesophagus,38534,840,0.98 [0.87-1.11],0.7663172660058317
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",46577,196,1.17 [0.91-1.51],0.2106730819134537
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",49489,196,1.17 [0.91-1.50],0.2324721254591214
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Cholecystitis,46770,389,1.12 [0.94-1.35],0.2002067029970373
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Cholelithiasis,48307,1926,1.07 [0.99-1.16],0.0999539793542644
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Chronic gastritis,38288,594,1.06 [0.92-1.23],0.4317077341406624
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Chronic pancreatitis,46477,96,0.83 [0.57-1.23],0.3574113616245711
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",50028,196,0.84 [0.64-1.10],0.2016828457589786
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Coeliac disease,47191,240,1.16 [0.92-1.45],0.2080246026138226
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Collagenous colitis,47034,159,0.97 [0.73-1.30],0.8373141484957299
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,50008,362,1.05 [0.87-1.26],0.6411580788527291
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Constipation,49810,3260,1.05 [0.98-1.11],0.158585864596929
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Crohn disease,47057,182,1.04 [0.80-1.36],0.7541323020075816
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",49618,132,0.95 [0.69-1.31],0.7702423985715295
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Crohn's disease NAS,47047,172,1.17 [0.90-1.52],0.2524431703755232
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Dental caries,48880,445,1.14 [0.96-1.35],0.123956649971133
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,45179,4338,1.04 [0.99-1.10],0.1504304648278787
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diseases of appendix,50066,357,0.99 [0.82-1.20],0.9209163982287096
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diseases of liver,50071,1637,1.07 [0.98-1.17],0.1288131653637999
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",46080,8386,1.02 [0.98-1.06],0.2798805251521307
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",49498,1063,1.10 [0.98-1.22],0.1006493683924714
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diseases of peritoneum,50136,922,1.01 [0.89-1.13],0.9303511755719104
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,48653,218,1.06 [0.83-1.35],0.6402246231684761
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diseases of salivary glands,48368,130,1.00 [0.73-1.38],0.9815561881452562
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diseases of the digestive system,49708,2757,1.04 [0.97-1.11],0.3035396348437536
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diseases of tongue,48398,215,0.82 [0.64-1.06],0.1367569103234782
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",49088,2707,1.07 [1.00-1.15],0.0562063889484518
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,41534,6135,1.02 [0.97-1.07],0.4262185089788093
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Duodenal ulcer,38083,389,1.05 [0.87-1.25],0.6312680996334976
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",50144,312,0.99 [0.80-1.22],0.9179260011489818
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,50131,106,1.27 [0.91-1.76],0.1589292675512838
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,48672,238,0.93 [0.73-1.18],0.5428258112124968
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,35686,287,1.09 [0.88-1.34],0.4306688836834825
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Functional dyspepsia,38764,1070,0.96 [0.86-1.08],0.5254044435567379
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Gastric ulcer,38393,699,1.04 [0.90-1.19],0.5991438489873955
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,42539,4845,1.04 [0.99-1.09],0.1625892457520762
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,38741,1047,1.04 [0.93-1.16],0.5360683664139636
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,38942,16119,1.03 [1.00-1.06],0.0320525547842169
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,GI-bleeding,49216,2265,1.03 [0.96-1.11],0.3962159311795338
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,48540,105,1.18 [0.84-1.66],0.3320356424259384
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,37301,2455,1.03 [0.96-1.11],0.4494625997994924
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",48555,121,1.04 [0.75-1.45],0.8030450474412916
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Hernia,47143,6302,1.03 [0.98-1.08],0.1951830319371704
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Impacted teeth,50144,98,1.40 [1.00-1.95],0.0472982199708088
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Impaction of intestines,35510,111,1.41 [1.03-1.93],0.030558498988366
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Inguinal hernia,42585,1744,1.02 [0.93-1.11],0.6611045686702961
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",41041,200,0.98 [0.76-1.26],0.8626062190009292
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,35588,189,0.87 [0.66-1.15],0.3287859916630832
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Intestinal malabsorption,47226,275,1.10 [0.89-1.36],0.3782706708410162
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,36471,1072,0.97 [0.87-1.09],0.6412315828494896
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,50249,720,1.09 [0.95-1.24],0.2114159667951614
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,48344,1469,1.12 [1.02-1.23],0.0176578235519161
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,48827,1952,1.09 [1.00-1.18],0.0391531773937726
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Oesophageal obstruction,38058,364,1.12 [0.93-1.35],0.2303908605007172
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Oesophagitis,38866,1172,1.05 [0.95-1.17],0.3567151394769561
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,50209,265,1.30 [1.06-1.60],0.0123857474788011
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,40973,132,1.05 [0.77-1.43],0.7616736591293495
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,38054,2655,1.03 [0.96-1.10],0.4313987344724669
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,46932,551,1.07 [0.92-1.24],0.4084866408407149
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,46685,304,1.20 [0.98-1.46],0.075297942717281
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of intestine,38804,3405,0.97 [0.91-1.03],0.3387718629142575
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of intestines,46393,10994,1.01 [0.97-1.04],0.7464678624853593
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,48352,402,1.20 [1.01-1.43],0.0374596627728184
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of liver,49773,1339,1.05 [0.95-1.16],0.3121375209246311
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,38975,1281,1.03 [0.93-1.14],0.5348855580883339
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of pancreas,46672,291,1.04 [0.84-1.29],0.7233015392794506
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,50003,789,1.00 [0.88-1.14],0.9790465448285076
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,39540,1846,0.99 [0.91-1.08],0.8011363768935307
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,49244,2293,1.03 [0.96-1.12],0.3775160355596977
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,48786,351,1.11 [0.92-1.35],0.2577222318901426
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,38747,3348,1.04 [0.98-1.11],0.2391433621610263
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),41619,3925,1.03 [0.97-1.09],0.3693480488594441
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,48623,189,0.92 [0.71-1.21],0.5644782353390796
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,48592,1717,1.09 [1.00-1.19],0.0553473114799797
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",36065,666,1.06 [0.92-1.22],0.397114572272237
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,50112,123,1.31 [0.97-1.77],0.0821686628421939
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,36353,954,0.99 [0.88-1.11],0.8668165727053995
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",47238,287,0.98 [0.79-1.22],0.8877296692666902
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Recurring oral aphthae,50285,110,0.89 [0.62-1.27],0.5255130809507773
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,48443,223,1.11 [0.88-1.41],0.3872991919589237
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Toxic colitis,46983,108,0.91 [0.64-1.30],0.6157954992581254
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,38210,516,1.03 [0.88-1.21],0.7321328194848684
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Ulcerative colitis,47182,307,1.06 [0.86-1.29],0.6008288817575016
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",47130,255,1.00 [0.79-1.25],0.9765592064182712
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Umbilical hernia,41367,526,0.93 [0.79-1.09],0.3653526544122021
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,35743,344,0.90 [0.73-1.10],0.2954085288933042
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Ventral hernia,41340,499,0.97 [0.83-1.15],0.7487483231439257
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XI Diseases of the digestive system,Volvulus,35558,159,0.75 [0.55-1.02],0.0671377401066658
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,50148,576,1.05 [0.91-1.22],0.488585454051927
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,49680,139,1.26 [0.94-1.68],0.1214779385132127
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,46310,311,1.08 [0.88-1.32],0.4732215246748954
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,49056,1349,1.02 [0.92-1.13],0.6968508896885262
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",48045,338,1.18 [0.98-1.43],0.0837417058973123
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,46788,789,1.06 [0.93-1.20],0.3958799544985489
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,49707,538,1.32 [1.14-1.52],0.000194702147524
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,50109,940,1.22 [1.09-1.37],0.0004082032997413
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,49263,94,1.29 [0.91-1.83],0.1490001142333516
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,47263,6239,1.03 [0.99-1.08],0.1879068114695997
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,49419,870,0.97 [0.86-1.10],0.6112318090302014
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,49166,617,0.98 [0.85-1.14],0.8374318372489102
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,49538,1831,1.04 [0.95-1.13],0.4025521736286472
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",50276,105,0.96 [0.67-1.37],0.8132001986861401
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,46112,113,1.03 [0.73-1.45],0.8657221860078852
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,48650,101,1.19 [0.84-1.68],0.317524127566834
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,49688,519,1.31 [1.13-1.52],0.0003057047455485
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,46884,885,1.03 [0.92-1.17],0.5965894625418346
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,46122,123,1.02 [0.74-1.42],0.899811799269516
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,50135,166,1.06 [0.81-1.41],0.6611901722865738
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,48078,371,1.25 [1.04-1.49],0.0153696788779645
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,49916,375,0.91 [0.75-1.10],0.3244539304582501
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,49293,124,1.20 [0.87-1.64],0.2629348724367576
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,46127,128,1.23 [0.91-1.66],0.1805097675008045
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,49175,3176,1.05 [0.98-1.12],0.1545133809605086
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",46955,956,1.05 [0.94-1.18],0.3824648714659191
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,46129,130,1.02 [0.74-1.40],0.9085415004167324
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,50136,595,0.98 [0.85-1.14],0.8119091340009275
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,49302,133,1.09 [0.80-1.48],0.6011776853346851
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,50029,488,0.99 [0.84-1.17],0.91871066158611
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,50203,631,1.02 [0.89-1.18],0.7451714482428793
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,46244,245,1.15 [0.92-1.44],0.2083677502983737
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,46525,526,0.84 [0.71-0.99],0.0350571623805297
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,50182,610,1.03 [0.89-1.19],0.7154498876910512
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",46457,458,1.22 [1.04-1.43],0.0175311516522776
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,50244,275,1.06 [0.85-1.32],0.6002329818606169
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,43135,211,1.20 [0.94-1.52],0.1390523657054423
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,45799,10969,1.02 [0.99-1.06],0.1992154310165579
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,43044,8214,1.02 [0.98-1.07],0.2451149087638574
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,43068,144,0.98 [0.72-1.33],0.8986046997616345
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,43613,297,1.21 [0.99-1.47],0.0690740271033382
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,43666,350,0.99 [0.82-1.21],0.9443697700857072
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,49818,180,1.09 [0.83-1.42],0.5419059889504265
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",43509,193,1.00 [0.77-1.30],0.9885070826831502
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,37040,2210,1.04 [0.96-1.12],0.299746996929802
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",50041,367,1.11 [0.92-1.33],0.2786710943166986
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,44187,871,1.15 [1.02-1.29],0.0206914406460607
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,42532,14122,1.03 [1.00-1.06],0.0460434639682953
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,46446,225,0.94 [0.74-1.20],0.6280169672053348
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,43218,294,0.96 [0.77-1.19],0.6822620565887053
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,44033,1109,1.17 [1.05-1.30],0.003796164688957
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,48502,5186,1.05 [1.00-1.11],0.047197861715738
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,43455,531,0.89 [0.75-1.04],0.1473382272059076
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,43347,423,1.22 [1.03-1.44],0.0228560009922813
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,43185,261,1.29 [1.05-1.60],0.0161555510053495
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,49065,130,1.01 [0.73-1.38],0.9735082326966186
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,38108,3278,0.99 [0.93-1.06],0.7949104993803471
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,35998,1168,1.13 [1.02-1.25],0.0187535355589509
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",50163,1152,1.14 [1.03-1.27],0.0133192440216635
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,34973,143,1.27 [0.96-1.69],0.0957365777744608
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),35483,653,0.98 [0.85-1.14],0.8300577972308486
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,43517,593,1.04 [0.90-1.21],0.6050899761717997
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,36064,1234,1.04 [0.94-1.15],0.4825480736029111
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,43424,108,1.33 [0.97-1.83],0.0804793591041068
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,44547,1231,1.09 [0.98-1.21],0.1008165001028205
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,43913,597,1.16 [1.00-1.34],0.0430240028126272
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,35985,1155,1.01 [0.91-1.12],0.8526899931528351
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,43078,154,1.32 [1.00-1.74],0.0463320668307075
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",43046,122,1.13 [0.82-1.56],0.4469862376910992
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,46356,135,1.08 [0.79-1.47],0.6368222516740327
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,49547,3326,1.00 [0.94-1.07],0.9998638821062292
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,48403,2182,0.98 [0.91-1.06],0.6930078488943098
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",50025,878,1.19 [1.05-1.34],0.004422398502263
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,39672,4842,1.05 [1.00-1.10],0.0767687372548931
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,34953,123,1.25 [0.92-1.70],0.1591587098082801
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,43106,182,1.24 [0.96-1.60],0.0952939353307947
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,34925,95,0.89 [0.61-1.30],0.531112922688668
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),35077,247,0.97 [0.77-1.22],0.7696135746659514
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,46693,472,0.99 [0.84-1.18],0.9442999222997392
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,46962,741,1.03 [0.91-1.18],0.612337709954153
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,50241,197,1.31 [1.03-1.67],0.027369849481485
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",46831,3515,1.06 [1.00-1.13],0.0476066344443092
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,43116,192,1.06 [0.82-1.38],0.655501452995324
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),35100,270,0.86 [0.69-1.08],0.203868809047765
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,44729,1413,1.07 [0.97-1.18],0.152411710109283
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,39007,4177,1.04 [0.98-1.09],0.213689859528519
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,49111,176,1.01 [0.77-1.33],0.9158174451510536
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,50269,133,1.37 [1.03-1.83],0.0323279511385271
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,43083,159,0.94 [0.70-1.27],0.693960368670294
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",45351,2427,1.11 [1.03-1.20],0.0037708870745878
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,43097,173,1.04 [0.79-1.38],0.7563422764299732
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,37981,3151,1.05 [0.99-1.12],0.1216970146993482
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,46440,219,0.97 [0.76-1.24],0.7972977836528078
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,43029,105,1.25 [0.90-1.75],0.1879978181358025
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,43620,304,0.91 [0.73-1.12],0.368926848065703
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,44005,1081,1.06 [0.95-1.18],0.2957290688130461
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,49624,689,1.13 [0.99-1.29],0.0687911511774067
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,44434,1118,1.07 [0.96-1.19],0.2197349596261753
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,50049,854,1.19 [1.06-1.34],0.0043807491108648
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,50262,107,1.42 [1.04-1.95],0.0295012589081281
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,43295,371,1.05 [0.87-1.27],0.5926918976149773
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,39822,1463,1.08 [0.98-1.19],0.1065919585707385
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,44061,1137,1.09 [0.98-1.21],0.1018422558164384
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],43373,449,0.90 [0.76-1.08],0.2496901608425305
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",34936,106,0.89 [0.62-1.27],0.5199712261120363
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,39657,4827,1.08 [1.02-1.13],0.0049133495729406
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,36101,1271,1.04 [0.94-1.15],0.4072120961937324
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,49391,456,1.13 [0.96-1.33],0.1430932714297796
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",50175,131,1.15 [0.85-1.57],0.3618369006561778
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",46099,99,1.00 [0.69-1.44],0.9938095173797524
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,34965,135,1.34 [1.01-1.78],0.0459531253023846
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,43517,201,1.25 [0.98-1.59],0.0721895072917842
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,35719,889,1.19 [1.06-1.34],0.0032678842435016
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,43527,603,1.01 [0.87-1.18],0.854734902241254
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,43808,492,1.24 [1.06-1.44],0.0070359323861814
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,43691,375,1.08 [0.90-1.29],0.435799546769942
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,39371,117,1.15 [0.83-1.59],0.3881372380014729
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",50270,115,1.31 [0.96-1.79],0.0935314066843945
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,44075,1151,1.04 [0.93-1.16],0.4733435006143514
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],49113,178,1.15 [0.88-1.49],0.3022313391117401
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,47940,5016,1.07 [1.01-1.12],0.0133405119691568
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",43182,258,0.92 [0.73-1.16],0.4994774118439999
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,44388,1072,1.11 [1.00-1.24],0.0598241790574184
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,47579,448,0.93 [0.78-1.11],0.4214267069612372
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,43715,399,1.25 [1.05-1.48],0.0118847522295416
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,46353,3037,1.03 [0.97-1.10],0.3209207130310589
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,45314,1998,1.05 [0.97-1.14],0.2332487579108794
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],43028,104,1.13 [0.80-1.60],0.4899177788817744
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,49191,256,1.09 [0.87-1.36],0.4430702192583766
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,43242,318,1.17 [0.96-1.43],0.1100378017898973
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,43073,149,0.90 [0.67-1.22],0.5082313402483523
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),34944,114,1.12 [0.81-1.56],0.5027894100154587
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Acute renal failure,48268,3058,1.17 [1.10-1.25],1.444129616218666e-06
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),20292,100,1.03 [0.71-1.48],0.8810723925456823
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,26439,112,0.92 [0.65-1.31],0.6399009363579364
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,49687,620,1.05 [0.91-1.22],0.46807161247814
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,49228,161,0.82 [0.61-1.11],0.1972550681122565
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,48182,2972,1.12 [1.05-1.20],0.0006667134316413
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,49884,161,1.60 [1.25-2.05],0.0001793046102218
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,49825,587,1.06 [0.92-1.23],0.4249978539832066
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Cystitis,44319,459,0.97 [0.82-1.15],0.7188730017886564
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Dialysis,45365,155,1.53 [1.18-1.99],0.0014014319761829
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,21916,3238,1.06 [1.00-1.13],0.0523599246723376
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Disorders of breast,26666,339,1.05 [0.86-1.27],0.6449534111942425
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Endometriosis,20368,176,0.99 [0.75-1.30],0.9191717701008608
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",20583,391,0.82 [0.68-1.00],0.0449043428039828
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,21189,997,0.96 [0.86-1.08],0.5139964894498681
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,41979,10454,1.03 [1.00-1.07],0.0699342356996047
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,49890,167,1.49 [1.16-1.92],0.0016172044647279
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Hydrocele,18876,198,1.02 [0.79-1.32],0.8689472702342528
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,45187,564,1.08 [0.93-1.26],0.3222543271295183
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,21216,2538,1.06 [0.99-1.14],0.1147914214231179
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,26597,393,0.83 [0.69-1.00],0.0540164980602792
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),18909,231,1.09 [0.86-1.38],0.4730608265985957
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Irregular menses,26670,126,0.68 [0.48-0.96],0.028615850909731
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Menorrhagia,20493,301,0.94 [0.75-1.16],0.5472354933093402
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,44010,150,0.93 [0.68-1.25],0.6216081976249239
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,22629,2437,0.97 [0.90-1.05],0.4757758026979508
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,18788,110,0.85 [0.59-1.22],0.3867337317345171
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,20332,140,1.15 [0.85-1.55],0.3588418353050441
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",50281,123,1.13 [0.82-1.55],0.4571226924637814
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",50290,127,0.69 [0.49-0.98],0.0372784116773443
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,48274,4414,1.04 [0.98-1.10],0.1888093443958469
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,45248,1388,1.06 [0.96-1.17],0.2541272730233999
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,26444,117,1.10 [0.79-1.52],0.5836757241193584
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,50172,934,1.12 [0.99-1.25],0.0622850346015875
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,18984,306,1.07 [0.87-1.31],0.5156383422147081
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,18957,279,1.17 [0.95-1.44],0.1489120975772326
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,18899,221,0.90 [0.70-1.16],0.4052770640534547
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,50229,137,1.08 [0.80-1.47],0.5989270674358919
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,47265,3405,1.07 [1.00-1.13],0.0425527198657104
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,26402,198,0.92 [0.71-1.20],0.5310727389700794
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,20346,154,1.13 [0.85-1.50],0.4136229421652513
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",20557,365,0.91 [0.75-1.11],0.3672167201970039
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,20300,108,1.16 [0.83-1.63],0.383145438385173
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,20398,206,1.19 [0.94-1.53],0.1537440663516424
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,45281,658,1.09 [0.95-1.26],0.2190799936549278
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,49549,311,1.12 [0.92-1.37],0.266137633847503
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,20501,309,1.05 [0.86-1.29],0.6135939129529846
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,20297,105,0.81 [0.56-1.17],0.2675118845583301
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,20826,634,0.94 [0.81-1.09],0.4224620243682739
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,20351,159,1.08 [0.81-1.43],0.5925718561881943
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,20778,586,1.03 [0.88-1.19],0.7312675010095594
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,49820,97,1.00 [0.69-1.45],0.9893083793389196
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",18940,262,1.18 [0.95-1.47],0.1307929195489349
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,49813,5190,1.12 [1.06-1.17],1.40752582592001e-05
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",44853,230,1.25 [0.99-1.57],0.0561681565105305
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,45465,255,0.92 [0.73-1.17],0.4897679637676683
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,49173,106,1.28 [0.92-1.78],0.1405522367516334
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Urethral stricture,44294,434,1.03 [0.86-1.22],0.7725955734042697
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Urolithiasis,49832,765,1.03 [0.91-1.18],0.608328602996608
NFKBIE,NF-kappa-B inhibitor epsilon,Chapter XIV Diseases of the genitourinary system,Uterine polyps,20328,136,1.22 [0.90-1.65],0.1948060802045434
